Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women
CONCLUSIONS: MHT is associated with statistically reduced CVD risk among white but not black women with PreDM or DM. Race is an effect modifier in the association between MHT use and CVD.PMID:35114556 | DOI:10.1016/j.atherosclerosis.2022.01.016
Source: Atherosclerosis - Category: Cardiology Authors: Yilin Yoshida Zhipeng Chen Robin L Baudier Marie Krousel-Wood Amanda H Anderson Vivian A Fonseca Franck Mauvais-Jarvis Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Disease | Hormonal Therapy | Hormones | Ischemic Stroke | Men | Menopause | Statistics | Stroke | Study | Women